Pihkal
The chemist's love affair with wonder
Description
In 1991, a chemist named Alexander Shulgin and his wife Ann published a fat, strange book through their own small press. Its title was an acronym — PIHKAL, for Phenethylamines I Have Known And Loved — and it did not behave like anything on the shelf beside it. The first half was a novel, more or less: two lightly fictionalized people named Shura and Alice, falling in love in middle age, arguing about God and chemistry and each other. The second half was a laboratory manual, 179 compounds laid out with the flat precision of a recipe: synthesis, dosage, duration, and then a paragraph of notes on what each substance did to the person who swallowed it. Shulgin was that person, most of the time.
He had a real pedigree. A Harvard dropout who finished a doctorate in biochemistry at Berkeley, he had worked for Dow Chemical, invented a profitable insecticide, and held a federal license that let him work legally with scheduled drugs. He is the reason MDMA — later known on the street as ecstasy — moved from a forgotten 1912 patent into the hands of therapists in the 1970s. And he ran much of his research out of a lab in a shed behind his house in the hills east of San Francisco, testing new molecules on himself, on Ann, and on a small circle of trusted friends who rated their own experiences on a scale he had devised.
PIHKAL was, among other things, a confession. It put the formulas in print precisely so no authority could bury them, and it married the coldest kind of technical writing to the warmest kind of personal one. The pairing was deliberate, and it is the thing that still makes the book hard to file.
The question we’re asking : What kind of book puts a marriage and a synthesis manual between the same covers, and why did the Shulgins insist the two belonged together?What we’ll see : How a backyard chemist turned his own nervous system into a laboratory, and what he was really claiming about the way a mind can be known.
Table of contents
01Chapter 1 — A pharmacologist with a lab in the backyard
Alexander Shulgin — Sasha to nearly everyone — was born in Berkeley in 1925, and the arc of his working life reads like a series of doors that quietly opened and then, one by one, closed. He served in the Navy, took his doctorate at Berkeley, and landed at Dow Chemical, where he synthesized a biodegradable insecticide called Zectran that made the company real money. That success bought him unusual freedom. For a while Dow let him follow his curiosity, and his curiosity had already turned, decisively, toward a single family of molecules.
The turning point was mescaline. Sometime in the late 1950s he took it and came away convinced that the vivid, reordered world he had just moved through was not conjured by the drug so much as unlocked by it — that the experience had been latent in him, and a few hundred milligrams of a plain white powder had merely opened the latch. For a chemist, this was an irresistible provocation. If a small structural cousin of adrenaline could do that, what could its cousins do? Phenethylamines became his life's work: a scaffold you could modify atom by atom, each variation a new question posed directly to the brain.
02Chapter 2 — Two halves that shouldn't fit in one book
Open PIHKAL and you are not in a laboratory at all. You are in a love story. The first several hundred pages follow Shura, a chemist who could be nobody but Sasha, and Alice, who is Ann — their meeting, their courtship, their fights, their eventual marriage in 1981 on a hilltop with the DEA administrator among the guests. It is autobiography wearing the thinnest of fictional disguises, and it is unashamedly romantic: two people in their fifties finding each other, and finding in each other a partner for a very particular kind of exploration.
Ann's presence changes the book's temperature. She was not a chemist but a lay therapist, drawn to the psyche's darker basements — she wrote openly about using these compounds to sit with grief, with shame, with the parts of a self that ordinary consciousness keeps locked away. Where Sasha brought the instrument-maker's patience, Ann brought the sense that what the instruments measured actually mattered to a human life. Their voices alternate through the narrative, and the marriage on the page is also a collaboration: his molecules, her map of what to do with the states they produced.
03Chapter 3 — The self as the only instrument
The catalogue's method was as unusual as its contents. Shulgin worked from a scale he built himself, running from a plus-minus that registered only a faint something, up through a full three that he reserved for the compounds that reorganized the mind completely. It was not a scale of pleasure or potency in any pharmacological textbook sense. It was a scale of how thoroughly a substance had moved the observer — and the observer was always, at bottom, the chemist himself, tasting his own creations one careful step at a time.
This is where PIHKAL parts company with modern pharmacology. The discipline had spent the twentieth century building itself around exactly the opposite principle: the double-blind trial, the placebo control, the researcher held at arm's length from the effect so that no wish or expectation could color the result. Shulgin knew all of this. He was a professional. And he chose, deliberately, a first-person method the field had ruled out of bounds — because the thing he wanted to know could not be reached from the outside. You cannot double-blind your way to what it feels like to have your sense of time come loose.
04Chapter 4 — What it means to know a thing from the inside
Strip away the shed and the DEA license and the alternating chapters, and PIHKAL is making a quiet, stubborn argument about knowledge itself. There are things about a mind, the Shulgins are saying, that can only be known from within it. You can measure serotonin and map receptors and chart dose-response curves all day, and you will still not have touched the question of what a person actually undergoes when a compound rearranges their inner world. That question has only one door, and it opens from the inside.
This puts the book in old and uncomfortable company. The demand that knowledge be detached, repeatable, stripped of the knower is one of the founding moves of modern science, and it has been extraordinarily productive. But it purchases that power by ruling certain questions out of order — precisely the questions about first-person experience that philosophers have circled for centuries without settling. Shulgin, a hard-nosed synthetic chemist, ended up defending the one kind of evidence his own discipline had learned to distrust: the report of the person who was there.
05Conclusion
The book they meant to be their legacy became, instead, evidence. After PIHKAL appeared with its synthesis instructions in plain print, the DEA raided the Lafayette lab in 1994 and Shulgin surrendered the license he had held for decades. He wrote a sequel, TIHKAL, about the tryptamines, and kept working until age closed the shed for good; he died in 2014. The formulas he refused to keep secret are still out there, exactly as he wanted, past the reach of anyone who might have preferred them lost.
Related books
